These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Myocardial toxicity of cyclosporin A: inhibition of calcium ATPase and nitric oxide synthase activities and attenuation by fructose-1,6-diphosphate in vitro.
    Author: Hutcheson AE, Rao MR, Olinde KD, Markov AK.
    Journal: Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):17-26. PubMed ID: 7582858.
    Abstract:
    Use of cyclosporin A (CsA) in transplantation medicine has been shown to cause a number of toxic cellular side effects, which has prompted a search for formulations that afford protection from these undesirable sequelae. Previously we demonstrated that fructose-1,6-diphosphate (FDP) can reverse a variety of toxic cellular effects that arise upon use of various chemical agents. The present studies were undertaken to study the effects of CsA on rat myocardial Ca2+, calmodulin (Cam)-dependent enzymes such as Ca2+ ATPase and nitric oxide synthase (NOS) and the role of FDP in attenuating these changes in vitro. Rat ventricular sarcoplasmic Ca2+ ATPase was studied by measuring the inorganic phosphorous liberated on ATP hydrolysis and rat heart 100,000 g fraction NOS activity by monitoring the formation of [3H]-citrulline in the presence of 10-1000 microM CsA and 1000 microM CsA + 1000 microns FDP in vitro. CsA in all concentrations significantly (P < 0.001) inhibited both Ca2+ ATPase and NOS activities of rat myocardium and FDP at 1000 microM concentration completely reversed the 1000 microM CsA-inhibited Ca2+ ATPase and cNOS activities of rat myocardium. These data indicate that CsA may inhibit Ca2+ ATPase and NOS activities in the rat myocardium through interference with its Ca2+/Cam-mediated events and thus may cause myocardial toxicity. FDP may reverse these changes.
    [Abstract] [Full Text] [Related] [New Search]